- $25.78m
- $82.48m
- CA$65.22m
- 52
- 93
- 14
- 52
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 59.8 | 44.2 | 57.5 | 68.9 | 65.2 |
Cost of Revenue | |||||
Gross Profit | 59.2 | 43.8 | 53.6 | 61 | 59.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 50.3 | 41 | 94.9 | 203 | 74.3 |
Operating Profit | 9.49 | 3.23 | -37.4 | -134 | -9.11 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.8 | -13.4 | -33.4 | -166 | -18.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.8 | -13.4 | -33.2 | -166 | -17.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.8 | -13.4 | -33.2 | -166 | -17.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.8 | -13.4 | -33.2 | -166 | -17.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.81 | -1.59 | -1.52 | -3.95 | -0.583 |
Special Dividends per Share |